NuCana PLC (NCNA)
1.23
-0.04
(-3.15%)
USD |
NASDAQ |
Nov 22, 16:00
1.235
0.00 (0.00%)
After-Hours: 20:00
NuCana Cash from Operations (Quarterly): -1.446M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -1.446M |
| March 31, 2024 | -7.462M |
| December 31, 2023 | 0.4825M |
| September 30, 2023 | -13.12M |
| June 30, 2023 | -7.697M |
| March 31, 2023 | -12.56M |
| December 31, 2022 | -9.406M |
| September 30, 2022 | 2.940M |
| June 30, 2022 | -10.65M |
| March 31, 2022 | -11.57M |
| December 31, 2021 | -13.84M |
| September 30, 2021 | -0.8644M |
| June 30, 2021 | -6.944M |
| March 31, 2021 | -11.13M |
| December 31, 2020 | -11.41M |
| Date | Value |
|---|---|
| September 30, 2020 | -6.851M |
| June 30, 2020 | -1.525M |
| March 31, 2020 | -7.958M |
| December 31, 2019 | -5.824M |
| September 30, 2019 | -9.654M |
| June 30, 2019 | -7.017M |
| March 31, 2019 | -7.936M |
| December 31, 2018 | -3.432M |
| September 30, 2018 | -4.839M |
| June 30, 2018 | -4.202M |
| March 31, 2018 | -3.836M |
| December 31, 2017 | -4.008M |
| September 30, 2017 | -2.643M |
| June 30, 2017 | -2.765M |
| March 31, 2017 | -1.827M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-13.84M
Minimum
Dec 2021
2.940M
Maximum
Sep 2022
-7.202M
Average
-7.697M
Median
Jun 2023
Cash from Operations (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | -54.45M |
| Biodexa Pharmaceuticals PLC | -- |
| TC BioPharm (Holdings) PLC | -3.055M |
| Mereo BioPharma Group PLC | -7.519M |
| Autolus Therapeutics PLC | -76.74M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.0053M |
| Cash from Financing (Quarterly) | -0.0888M |
| Free Cash Flow | -22.00M |
| Free Cash Flow Per Share (Quarterly) | -0.6922 |
| Free Cash Flow Yield | -828.9% |